Humana Inc. (0J6Z.L)
USD 257.72
(-0.95%)
USD 257.72
(-0.95%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 106.37 Billion USD | 14.48% |
| 2022 | 92.92 Billion USD | 11.09% |
| 2021 | 83.64 Billion USD | 8.36% |
| 2020 | 77.19 Billion USD | 18.88% |
| 2019 | 64.93 Billion USD | 14.03% |
| 2018 | 56.94 Billion USD | 5.84% |
| 2017 | 53.8 Billion USD | -1.11% |
| 2016 | 54.4 Billion USD | 0.21% |
| 2015 | 54.28 Billion USD | 11.94% |
| 2014 | 48.5 Billion USD | 17.4% |
| 2013 | 41.31 Billion USD | 5.59% |
| 2012 | 39.12 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 29.39 Billion USD | -0.48% |
| 2024 Q1 | 29.61 Billion USD | 11.9% |
| 2024 Q2 | 29.54 Billion USD | -0.24% |
| 2023 Q2 | 26.74 Billion USD | 0.02% |
| 2023 Q1 | 26.74 Billion USD | 19.18% |
| 2023 FY | 106.44 Billion USD | 14.55% |
| 2023 Q3 | 26.42 Billion USD | -1.21% |
| 2023 Q4 | 26.46 Billion USD | 0.15% |
| 2022 Q4 | 22.43 Billion USD | -1.58% |
| 2022 Q2 | 23.66 Billion USD | -1.28% |
| 2022 Q1 | 23.97 Billion USD | 14.02% |
| 2022 FY | 92.92 Billion USD | 11.09% |
| 2022 Q3 | 22.79 Billion USD | -3.65% |
| 2021 Q2 | 20.64 Billion USD | -0.11% |
| 2021 Q4 | 21.02 Billion USD | -3.37% |
| 2021 FY | 83.64 Billion USD | 8.36% |
| 2021 Q1 | 20.66 Billion USD | 8.43% |
| 2021 Q3 | 21.75 Billion USD | 5.38% |
| 2020 Q1 | 18.93 Billion USD | 16.2% |
| 2020 Q3 | 20.07 Billion USD | 5.2% |
| 2020 Q4 | 19.06 Billion USD | -5.05% |
| 2020 FY | 77.19 Billion USD | 18.88% |
| 2020 Q2 | 19.08 Billion USD | 0.78% |
| 2019 FY | 64.93 Billion USD | 14.03% |
| 2019 Q4 | 16.29 Billion USD | 0.33% |
| 2019 Q3 | 16.24 Billion USD | -0.02% |
| 2019 Q2 | 16.24 Billion USD | 0.86% |
| 2019 Q1 | 16.1 Billion USD | 13.69% |
| 2018 Q4 | 14.16 Billion USD | -0.27% |
| 2018 Q2 | 14.25 Billion USD | -0.14% |
| 2018 FY | 56.94 Billion USD | 5.84% |
| 2018 Q1 | 14.27 Billion USD | 8.26% |
| 2018 Q3 | 14.2 Billion USD | -0.37% |
| 2017 FY | 53.8 Billion USD | -1.11% |
| 2017 Q3 | 13.28 Billion USD | -1.86% |
| 2017 Q1 | 13.76 Billion USD | 6.86% |
| 2017 Q4 | 13.18 Billion USD | -0.7% |
| 2017 Q2 | 13.53 Billion USD | -1.66% |
| 2016 Q3 | 13.69 Billion USD | -2.23% |
| 2016 FY | 54.4 Billion USD | 0.21% |
| 2016 Q4 | 12.87 Billion USD | -5.96% |
| 2016 Q2 | 14 Billion USD | 1.5% |
| 2016 Q1 | 13.8 Billion USD | 3.29% |
| 2015 Q1 | 13.83 Billion USD | 12.21% |
| 2015 FY | 54.28 Billion USD | 11.94% |
| 2015 Q4 | 13.36 Billion USD | -0.01% |
| 2015 Q3 | 13.36 Billion USD | -2.69% |
| 2015 Q2 | 13.73 Billion USD | -0.73% |
| 2014 Q4 | 12.32 Billion USD | 0.74% |
| 2014 Q2 | 12.22 Billion USD | 4.35% |
| 2014 FY | 48.5 Billion USD | 17.4% |
| 2014 Q1 | 11.71 Billion USD | 14.97% |
| 2014 Q3 | 12.23 Billion USD | 0.13% |
| 2013 Q1 | 10.48 Billion USD | 9.72% |
| 2013 Q2 | 10.32 Billion USD | -1.57% |
| 2013 Q3 | 10.31 Billion USD | -0.02% |
| 2013 Q4 | 10.18 Billion USD | -1.28% |
| 2013 FY | 41.31 Billion USD | 5.59% |
| 2012 Q3 | 9.65 Billion USD | -0.49% |
| 2012 FY | 39.12 Billion USD | 0.0% |
| 2012 Q2 | 9.69 Billion USD | 0.0% |
| 2012 Q4 | 9.55 Billion USD | -0.97% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -29755.262% |
| Accuray Incorporated | 446.55 Million USD | -23721.243% |
| Align Technology, Inc. | 3.86 Billion USD | -2654.191% |
| Elevance Health Inc. | 171.34 Billion USD | 37.916% |
| AxoGen, Inc. | 159.01 Million USD | -66796.838% |
| Boston Scientific Corporation | 14.24 Billion USD | -647.008% |
| CVS Health Corporation | 357.77 Billion USD | 70.268% |
| Cardinal Health, Inc. | 226.82 Billion USD | 53.103% |
| Centene Corporation | 141.26 Billion USD | 24.7% |
| DaVita Inc. | 12.14 Billion USD | -776.217% |
| HCA Healthcare, Inc. | 64.96 Billion USD | -63.733% |
| Hologic, Inc. | 4.03 Billion USD | -2539.357% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -2805.637% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | -774.671% |
| Masimo Corporation | 2.04 Billion USD | -5093.789% |
| McKesson Corporation | 308.95 Billion USD | 65.569% |
| Patterson Companies, Inc. | 6.56 Billion USD | -1519.513% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -1049.741% |
| ResMed Inc. | 4.68 Billion USD | -2170.379% |
| Henry Schein, Inc. | 12.33 Billion USD | -762.096% |
| Teladoc Health, Inc. | 2.6 Billion USD | -3987.511% |
| Universal Health Services, Inc. | 14.28 Billion USD | -644.813% |
| Veeva Systems Inc. | 2.36 Billion USD | -4400.369% |
| Baxter International Inc. | 14.81 Billion USD | -618.112% |
| Becton, Dickinson and Company | 19.37 Billion USD | -449.112% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -1393.157% |
| Danaher Corporation | 23.89 Billion USD | -345.266% |
| Stryker Corporation | 20.49 Billion USD | -418.948% |
| Medtronic plc | 32.36 Billion USD | -228.68% |